Cost-effectiveness analysis of the tislelizumab versus docetaxel for advanced or metastatic non-small-cell lung cancer in China
Article in Frontiers in Public Health (July 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Frontiers in Public Health (July 2024)
Article in Current Medical Research and Opinion (January 2024)
Article in Life Sciences (January 2024)